Survival benefit of direct-acting antiviral agents on HCV-related HCC

被引：0

作者：

Chang, Shao-Hsuan ^{[1
]}

Cabrera, Roniel ^{[2
]}

Wilson, Debbie ^{[1
]}

Park, Haesuk ^{[1
]}

Park, Chanhyun ^{[3
]}

机构：

[1] Univ Florida, Pharmaceut Outcomes & Policy, Coll Pharm, Gainesville, FL USA

[2] Univ Florida, Div Gastroenterol Hepatol & Nutr, Coll Med, Gainesville, FL USA

[3] Univ Texas Austin, Hlth Outcomes Div, Coll Pharm, Austin, TX USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

1279

引用

页码：604 / 604

页数：1

共 50 条

[21] HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs) [J].

Gaetano La Manna .

Journal of Nephrology, 2018, 31 :185-187

[22] HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs) [J].

La Manna, Gaetano .

JOURNAL OF NEPHROLOGY, 2018, 31 (02) :185-187

[23] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis [J].

Renzulli, Matteo ;

Buonfiglioli, Federica ;

Conti, Fabio ;

Brocchi, Stefano ;

Serio, Ilaria ;

Foschi, Francesco Giuseppe ;

Caraceni, Paolo ;

Mazzella, Giuseppe ;

Verucchi, Gabriella ;

Golfieri, Rita ;

Andreone, Pietro ;

Brillanti, Stefano .

EUROPEAN RADIOLOGY, 2018, 28 (02) :506-513

[24] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis [J].

Matteo Renzulli ;

Federica Buonfiglioli ;

Fabio Conti ;

Stefano Brocchi ;

Ilaria Serio ;

Francesco Giuseppe Foschi ;

Paolo Caraceni ;

Giuseppe Mazzella ;

Gabriella Verucchi ;

Rita Golfieri ;

Pietro Andreone ;

Stefano Brillanti .

European Radiology, 2018, 28 :506-513

[25] Evaluation of HCC in Setting of Direct-Acting Antiviral Therapy [J].

Balitzer, Dana ;

Umetsu, Sarah .

LABORATORY INVESTIGATION, 2019, 99

[26] Evaluation of HCC in Setting of Direct-Acting Antiviral Therapy [J].

Balitzer, Dana ;

Umetsu, Sarah .

MODERN PATHOLOGY, 2019, 32

[27] Pretransplantation Direct-acting Antivirals Provides a Safe and Effective without Increase Recurrence of Hepatocellular Carcinoma in HCV-related HCC Patients [J].

Yin, S. M. ;

Chen, C. L. ;

Lin, C. C. ;

Wang, C. C. ;

Wang, S. H. ;

Liu, Y. W. ;

Yong, C. C. ;

Lin, T. L. ;

Li, W. F. ;

Lin, Y. H. ;

Chan, Y-C ;

Yeh, C-S .

TRANSPLANTATION, 2017, 101 (05) :42-43

[28] Role of abbreviated MRI protocol for screening of HCC in HCV related cirrhotic patients prior to direct-acting antiviral treatment [J].

Ahmed, Nora Nabil Abdou ;

El Gaafary, Sahar Mohamed ;

Elia, Remon Zaher ;

Abdulhafiz, Essam Mohamed .

EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2020, 51 (01)

[29] Role of abbreviated MRI protocol for screening of HCC in HCV related cirrhotic patients prior to direct-acting antiviral treatment [J].

Nora Nabil Abdou Ahmed ;

Sahar Mohamed El Gaafary ;

Remon Zaher Elia ;

Essam Mohamed Abdulhafiz .

Egyptian Journal of Radiology and Nuclear Medicine, 51

[30] Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals [J].

Russo, Francesco Paolo ;

Zanetto, Alberto ;

Campello, Elena ;

Bulato, Cristiana ;

Shalaby, Sarah ;

Spiezia, Luca ;

Gavasso, Sabrina ;

Franceschet, Enrica ;

Radu, Claudia ;

Senzolo, Marco ;

Burra, Patrizia ;

Lisman, Ton ;

Simioni, Paolo .

LIVER INTERNATIONAL, 2018, 38 (12) :2210-2218

← 1 2 3 4 5 →